Literature DB >> 19631175

Natriuretic peptides in the diagnosis and management of chronic heart failure.

Guido Boerrigter1, Lisa C Costello-Boerrigter, John C Burnett.   

Abstract

Circulating levels of the BNP system can help in the diagnosis of cardiovascular disease and provide prognostic information not only for patients who have HF but also for the general population and other patient groups. Changes over time also carry prognostic information, and studies are assessing BNP-guided treatment strategies. With the identification of circulating molecular forms of BNP, new insights regarding the biology of the BNP system are emerging that may improve the diagnostic and prognostic value of BNP. Likewise, accounting for rs198389 (a common single nucleotide polymorphism that increases BNP levels) may help to further refine the use of components of the BNP system as biomarkers.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19631175      PMCID： PMC2785540          DOI： 10.1016/j.hfc.2009.04.002

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  52 in total

1.  Molecular forms of human brain natriuretic peptide in plasma.

Authors:  Hiroyuki Shimizu; Keiichi Masuta; Kazuyoshi Aono; Hidehisa Asada; Kazuyuki Sasakura; Mikio Tamaki; Kenji Sugita; Kazuo Yamada
Journal:  Clin Chim Acta       Date:  2002-02       Impact factor: 3.786

2.  Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Inder S Anand; Lloyd D Fisher; Yann-Tong Chiang; Roberto Latini; Serge Masson; Aldo P Maggioni; Robert D Glazer; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

3.  Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

Authors:  D R Murdoch; T A McDonagh; J Byrne; L Blue; R Farmer; J J Morton; H J Dargie
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

4.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

5.  Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

Authors:  Scott D Cramer; Bao-Li Chang; Anuradha Rao; Gregory A Hawkins; S Lilly Zheng; Wendy N Wade; Roger T Cooke; Leanne N Thomas; Eugene R Bleecker; William J Catalona; David A Sterling; Deborah A Meyers; Jill Ohar; Jianfeng Xu
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

6.  Natural history of asymptomatic left ventricular systolic dysfunction in the community.

Authors:  Thomas J Wang; Jane C Evans; Emelia J Benjamin; Daniel Levy; Elizabeth C LeRoy; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

7.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

8.  Heritability and genetic linkage of plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Diane Corey; Eric P Leip; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

9.  Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

Authors:  Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Eric P Leip; Thomas J Wang; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

10.  Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.

Authors:  Eric E Niederkofler; Urban A Kiernan; Jessica O'Rear; Santosh Menon; Syed Saghir; Andrew A Protter; Randall W Nelson; Ute Schellenberger
Journal:  Circ Heart Fail       Date:  2008-10-14       Impact factor: 8.790
View more
  23 in total

1.  Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.

Authors:  Deborah M Dickey; Kathryn A Barbieri; Christopher M McGuirk; Lincoln R Potter
Journal:  Mol Pharmacol       Date:  2010-06-08       Impact factor: 4.436

2.  Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.

Authors:  Chirag R Parikh; Steven G Coca; Heather Thiessen-Philbrook; Michael G Shlipak; Jay L Koyner; Zhu Wang; Charles L Edelstein; Prasad Devarajan; Uptal D Patel; Michael Zappitelli; Catherine D Krawczeski; Cary S Passik; Madhav Swaminathan; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 10.121

Review 3.  Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Authors:  Massimo Volpe; Speranza Rubattu; John Burnett
Journal:  Eur Heart J       Date:  2013-11-13       Impact factor: 29.983

Review 4.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

5.  CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.

Authors:  Raffaele Altara; Marco Manca; Marleen H Hessel; Yumei Gu; Laura C van Vark; K Martijn Akkerhuis; Jan A Staessen; Harry A J Struijker-Boudier; George W Booz; W Matthijs Blankesteijn
Journal:  J Cardiovasc Transl Res       Date:  2016-06-06       Impact factor: 4.132

6.  Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.

Authors:  Misa Valo; Annette Wons; Albert Moeller; Claudius Teupe
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

7.  Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.

Authors:  B-Y Chen; R Tie; P Qu; M-Z Zhu; X-X Zhu; J Jin; J Yu
Journal:  J Endocrinol Invest       Date:  2011-05-17       Impact factor: 4.256

8.  Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation.

Authors:  Naveen L Pereira; Dong Lin; Linda Pelleymounter; Irene Moon; Gail Stilling; Bruce W Eckloff; Eric D Wieben; Margaret M Redfield; John C Burnett; Vivien C Yee; Richard M Weinshilboum
Journal:  Circ Cardiovasc Genet       Date:  2013-03-14

9.  Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women.

Authors:  Mirjam Ljunggren; Bertil Lindahl; Jenny Theorell-Haglöw; Eva Lindberg
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

10.  Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.

Authors:  Lisa C Costello-Boerrigter; Harald Lapp; Guido Boerrigter; Amir Lerman; Alexander Bufe; Fima Macheret; Denise M Heublein; Catherine Larue; John C Burnett
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.